Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Am J Pathol ; 188(2): 336-342, 2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-29128566

RESUMEN

Treacher Collins syndrome (TCS) is a rare congenital birth disorder (1 in 50,000 live births) characterized by severe craniofacial defects. Recently, the authors' group unfolded the pathogenesis of polr1c Type 3 TCS by using the zebrafish model. Facial development depends on the neural crest cells, in which polr1c plays a role in regulating their expression. In this study, the authors aimed to identify the functional time window of polr1c in TCS by the use of photo-morpholino to restore the polr1c expression at different time points. Results suggested that the restoration of polr1c at 8 hours after fertilization could rescue the TCS facial malformation phenotype by correcting the neural crest cell expression, reducing the cell death, and normalizing the p53 mRNA expression level in the rescued morphants. However, such recovery could not be reproduced if the polr1c is restored after 30 hours after fertilization.


Asunto(s)
ARN Polimerasas Dirigidas por ADN/fisiología , Terapias Fetales/métodos , Terapia Genética/métodos , Disostosis Mandibulofacial/prevención & control , Animales , Muerte Celular/genética , ARN Polimerasas Dirigidas por ADN/genética , Modelos Animales de Enfermedad , Desarrollo Embrionario/fisiología , Cara/embriología , Regulación del Desarrollo de la Expresión Génica/fisiología , Genes p53 , Disostosis Mandibulofacial/embriología , Disostosis Mandibulofacial/genética , Disostosis Mandibulofacial/patología , Morfolinos , Cresta Neural/metabolismo , Fenotipo , Factores de Tiempo , Pez Cebra
2.
Biochim Biophys Acta ; 1862(6): 1147-58, 2016 06.
Artículo en Inglés | MEDLINE | ID: mdl-26972049

RESUMEN

Treacher Collins Syndrome (TCS) is a rare congenital birth disorder (1 in 50,000 live births) characterized by severe craniofacial defects, including the downward slanting palpebral fissures, hypoplasia of the facial bones, and cleft palate (CP). Over 90% of patients with TCS have a mutation in the TCOF1 gene. However, some patients exhibit mutations in two new causative genes, POLR1C and POLR1D, which encode subunits of RNA polymerases I and III, that affect ribosome biogenesis. In this study, we examine the role of POLR1C in TCS using zebrafish as a model system. Our data confirmed that polr1c is highly expressed in the facial region, and dysfunction of this gene by knockdown or knock-out resulted in mis-expression of neural crest cells during early development that leads to TCS phenotype. Next generation sequencing and bioinformatics analysis of the polr1c mutants further demonstrated the up-regulated p53 pathway and predicted skeletal disorders. Lastly, we partially rescued the TCS facial phenotype in the background of p53 mutants, which supported the hypothesis that POLR1C-dependent type 3 TCS is associated with the p53 pathway.


Asunto(s)
Disostosis Mandibulofacial/genética , Disostosis Mandibulofacial/patología , Proteínas de Pez Cebra/genética , Pez Cebra/genética , Animales , Modelos Animales de Enfermedad , Regulación del Desarrollo de la Expresión Génica , Técnicas de Silenciamiento del Gen , Técnicas de Inactivación de Genes , Humanos , Mutación , Cresta Neural/metabolismo , Cresta Neural/patología , Proteína p53 Supresora de Tumor/genética , Pez Cebra/embriología
3.
Can J Diabetes ; 38(1): 17-21, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24485208

RESUMEN

OBJECTIVE: To assess the effect of patient use of an online patient portal on diabetes outcomes. METHODS: Patients included were those with diabetes who were newly referred to a Vancouver-based tertiary care diabetologist between April 2008 and October 2012. Each patient was assessed by the diabetologist, received initial diabetes education and was referred, as necessary, for further education and self-management training. All patients who provided an e-mail address at registration were invited to open an online patient portal account. The portal provided access to diabetes education material, personal laboratory values and a messaging system allowing communication with the diabetologist and staff. Patients who logged in 1 or more times were defined as portal users (n=50); patients who never logged in to the portal were defined as non-users (n=107). A1C was measured at 2 time points: at baseline (i.e. initial, in-clinic visit) and at last follow up (visit no less than 6 months and no more than 2 years after the initial visit). Because usership is self-selected, propensity score matching was used to create comparable user/non-user groups based on available baseline covariates. RESULTS: Compared to non-users, a higher proportion of users achieved A1C ≤7% at follow up (56% vs. 32%) (p=0.031). CONCLUSION: Accessing an online patient portal is associated with improved glycemic control.


Asunto(s)
Diabetes Mellitus/terapia , Registros Electrónicos de Salud , Internet , Autocuidado/métodos , Telemedicina/métodos , Adulto , Anciano , Femenino , Educación en Salud/métodos , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos
4.
Arterioscler Thromb Vasc Biol ; 30(11): 2196-204, 2010 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-20724702

RESUMEN

OBJECTIVE: Ferlins are known to regulate plasma membrane repair in muscle cells and are linked to muscular dystrophy and cardiomyopathy. Recently, using proteomic analysis of caveolae/lipid rafts, we reported that endothelial cells (EC) express myoferlin and that it regulates membrane expression of vascular endothelial growth factor receptor 2 (VEGFR-2). The goal of this study was to document the presence of other ferlins in EC. METHODS AND RESULTS: EC expressed another ferlin, dysferlin, and that in contrast to myoferlin, it did not regulate VEGFR-2 expression levels or downstream signaling (nitric oxide and Erk1/2 phosphorylation). Instead, loss of dysferlin in subconfluent EC resulted in deficient adhesion followed by growth arrest, an effect not observed in confluent EC. In vivo, dysferlin was also detected in intact and diseased blood vessels of rodent and human origin, and angiogenic challenge of dysferlin-null mice resulted in impaired angiogenic response compared with control mice. Mechanistically, loss of dysferlin in cultured EC caused polyubiquitination and proteasomal degradation of platelet endothelial cellular adhesion molecule-1 (PECAM-1/CD31), an adhesion molecule essential for angiogenesis. In addition, adenovirus-mediated gene transfer of PECAM-1 rescued the abnormal adhesion of EC caused by dysferlin gene silencing. CONCLUSIONS: Our data describe a novel pathway for PECAM-1 regulation and broaden the functional scope of ferlins in angiogenesis and specialized ferlin-selective protein cargo trafficking in vascular settings.


Asunto(s)
Adhesión Celular/fisiología , Células Endoteliales/fisiología , Proteínas de la Membrana/fisiología , Proteínas Musculares/fisiología , Neovascularización Patológica/fisiopatología , Animales , Bovinos , Proliferación Celular , Células Cultivadas , Regulación hacia Abajo , Disferlina , Humanos , Proteínas de la Membrana/biosíntesis , Ratones , Proteínas Musculares/biosíntesis , Molécula-1 de Adhesión Celular Endotelial de Plaqueta/fisiología , Receptor 2 de Factores de Crecimiento Endotelial Vascular/fisiología
5.
Cancer Res ; 77(21): 5886-5899, 2017 11 01.
Artículo en Inglés | MEDLINE | ID: mdl-28883005

RESUMEN

Esophageal squamous cell carcinoma (ESCC) has a generally poor prognosis, and molecular markers to improve early detection and predict outcomes are greatly needed. Here, we report that the BMP-binding follistatin-like protein FSTL1 is overexpressed in ESCCs, where it correlates with poor overall survival. Genetic amplification of FSTL1 or chromosome 3q, where it is located, occurred frequently in ESCC, where FSTL1 copy number correlated positively with higher FSTL1 protein expression. Elevating FSTL1 levels by various means was sufficient to drive ESCC cell proliferation, clonogenicity, migration, invasion, self-renewal, and cisplatin resistance in vitro and tumorigenicity and distant metastasis in vivo Conversely, FSTL1 attenuation by shRNA or neutralizing antibody elicited the opposite effects in ESCC cells. mRNA profiling analyses suggested that FSTL1 drives ESCC oncogenesis and metastasis through various pathways, with deregulation of NFκB and BMP signaling figuring prominently. Cross-talk between the NFκB and BMP pathways was evidenced by functional rescue experiments using inhibitors of NFκB and TLR4. Our results establish the significance of FSTL1 in driving oncogenesis and metastasis in ESCC by coordinating NFκB and BMP pathway control, with implications for its potential use as a diagnostic or prognostic biomarker and as a candidate therapeutic target in this disease setting. Cancer Res; 77(21); 5886-99. ©2017 AACR.


Asunto(s)
Proteínas Morfogenéticas Óseas/metabolismo , Carcinoma de Células Escamosas/metabolismo , Neoplasias Esofágicas/metabolismo , Proteínas Relacionadas con la Folistatina/metabolismo , FN-kappa B/metabolismo , Adulto , Anciano , Anciano de 80 o más Años , Animales , Western Blotting , Carcinoma de Células Escamosas/genética , Carcinoma de Células Escamosas/patología , Línea Celular Tumoral , Resistencia a Antineoplásicos/genética , Neoplasias Esofágicas/genética , Neoplasias Esofágicas/patología , Femenino , Proteínas Relacionadas con la Folistatina/genética , Perfilación de la Expresión Génica/métodos , Regulación Neoplásica de la Expresión Génica , Humanos , Masculino , Ratones Endogámicos BALB C , Ratones Desnudos , Persona de Mediana Edad , Metástasis de la Neoplasia , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transducción de Señal/genética , Trasplante Heterólogo , Adulto Joven
6.
Int J Biochem Cell Biol ; 45(8): 1921-6, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23732111

RESUMEN

Osmoregulation is an essential mechanism for euryhaline fish. Gill cells undergo rapid mechanism to maintain the cellular homeostasis during osmotic stress. Reports have suggested that gill cells may be able to migrate between primary filament and secondary lamella during seawater acclimination. However, the factor that can trigger such process is not well-known. Previously, we identified the osmotic stress transcription factor 1b (Ostf1b) in medaka and found that it is an early hypertonic responsive gene and can activate the c-Jun N-terminal kinase (JNK) pathway. In this report, we aim to know if Ostf1b plays the role in the migration. Ostf1b was ectopic expressed in the human embryonic kidney cell line (HEK293) to understand the Ostf1b function. Results clearly demonstrated that Ostf1b could constitutively activate the Rho kinase 1 (ROCK1) and myosin light chain 2 (MLC2) signalling pathway that promotes cell migration, epithelial mesenchymal transition (EMT) and cytoskeletal dynamics through stress fibre formation. The study supports the notion of cell migration and cytoskeleton rearrangement theories in osmoregulation.


Asunto(s)
Movimiento Celular , Transición Epitelial-Mesenquimal , Factores de Transcripción/metabolismo , Miosinas Cardíacas/metabolismo , Regulación de la Expresión Génica , Células HEK293 , Humanos , Cadenas Ligeras de Miosina/metabolismo , Fenotipo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Transducción de Señal/genética , Fibras de Estrés/metabolismo , Proteínas de Uniones Estrechas/metabolismo , Quinasas Asociadas a rho/metabolismo , Proteína de Unión al GTP rhoA/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA